CHECK-IT
Report
- Report Number
- 3016521623-2022-00271
- Event Type
- Malfunction
- Date Received
- August 8, 2022
- Date of Event
- July 25, 2022
- Report Date
- August 4, 2022
- Manufacturer
- LUCIRA HEALTH, INC.
- Product Code
- QJR
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TX, US
- Reporter Occupation
- OTHER
Narratives
PRODUCT HAS NOT BEEN RETURNED. THE CUSTOMER PROVIDED INFORMATION PERTAINING TO TWO KIT LOT NUMBERS (K08A110401224M2 AND K08A111001223M2) REPORTED TO BE ASSOCIATED WITH THE ALLEGED FALSE POSITIVES. A REVIEW OF EXISTING CAPAS, SCARS AND NCMRS WERE COMPLETED AND THERE ARE NO PRIOR RECORDS RELATED TO "FALSE POSITIVE" FAILURE MODE FOR THESE LOTS. THERE ARE 0 ADDITIONAL COMPLAINTS FROM THIS CUSTOMER ASSOCIATED WITH A "FALSE POSITIVE" FAILURE MODE PER TRENDING REVIEW FOR KIT LOT NUMBER K08A110401224M2. HOWEVER, THERE IS ONE PREVIOUS ALLEGED FALSE POSITIVE REPORTED FROM A DIFFERENT CUSTOMER: ((B)(4)/3016521623-2022-00162; RECEIPT DATE 04/15/2022), ASSOCIATED WITH KIT LOT NUMBER K08A111001223M2. A DHR REVIEW WAS CONDUCTED FOR TWO KIT LOT NUMBERS K08A110401224M2 AND K08A111001223M2. THERE WERE 0 DISCREPANCIES FOUND (ALL LOTS PASSED IN TOTAL PER THE SAMPLING PLAN). DHR REVIEW FOR KIT LOT NUMBER K08A110401224M2 : DHR REVIEW KIT LOT# K08A110401224M2: SAMPLE VIAL LOT DHR REVIEW: 2112203, 2112204, 2112287, 2112263, 2112322, 2112323, 2112321, 2112361, 2112323, 2112362, (ASSOCIATED INTERNAL LOT # 210762-2KI, 210762-2KJ, 211346.1-1B, 211346.1-1F, 211346.1-1R, 211346.1-1S, 211346.1-1T, 2113461-2I, 211346.1-1S, 2113461-2K). TEST LOT DHRS REVIEW: 2112221, 2112232, 2112270, 2112271, 2112271, 2112300, 2112326, 2112270, 2112315, 2112285, 2112285, 2112300, 2112302, 2112302, 2112302, 2112326, 2112315, 2112315, 2112349, 2112369, 2112369 (ASSOCIATED INTERNAL LOT # 210762-26E, 210762-26K, 211346.2-1D, 211346.2-1E, 211346.2-1G, 211346.2-1Q, 2113462-1R, 211346.2-1L, 211346.2-2R, 211346.2-1M, 211346.2-1N, 211346.2-1O, 2113462-1Z, 2113462-2B, 2113462-2D, 2113462-2F, 211346.2-2N, 211346.2-2P, 2113462-2V, 2113462-3K, 2113462-3P. DHR REVIEW FOR KIT LOT NUMBER K08A111001223M2 : SAMPLE VIAL LOT DHR REVIEW: 2111287, 2111309, 2111289, 2111290, 2111328, 2112037, 2112088, 2112288, 2112289, 2112295, 2112319, 2112291, 2112262 (ASSOCIATED INTERNAL LOT # 210762-2HE, 210762-2HK, 210762-2HL, 210762-2HO, 210762-2HR, 210762-2IG, 210762-2IZ, 211346.1-1I, 211346.1-1J, 211346.1-1K, 211346.1-1P, 211346.1-1D, 211346.1-1E). TEST LOT DHRS REVIEW: 2112301, 2112301, 2112301, 2112301, 2112327, 2112302, 2112326, 2112326, 2112326, 2112327, 2112315 (ASSOCIATED INTERNAL LOT # 2113462-1S, 2113462-1V, 2113462-1W, 2113462-1X, 2113462-1Y, 2113462-1Z, 2113462-2H, 2113462-2J, 2113462-2K, 2113462-2M, 211346.2-2O). BASED ON REVIEW OF THE PRODUCT'S FMEAS AND RISK ASSESSMENT DOCUMENTATION, FALSE POSITIVE TEST RESULTS ARE A KNOWN POSSIBLE OUTCOME REGARDING THIS ISSUE UNDER EVALUATION, REFER TO FMEA-001 AND FMEA-004. (B)(4). BASED ON THE LIMITED INFORMATION AVAILABLE, ROOT CAUSE CANNOT BE DETERMINED. POTENTIAL ROOT CAUSES INCLUDE BUT ARE NOT LIMITED TO: ENVIRONMENTAL CONTAMINATION, LOW VIRAL LOAD, AND/OR DEVICE FAILURE. LUCIRA HEALTH WILL CONTINUE TO MONITOR TRENDS RELATED TO FALSE POSITIVE RESULTS IN ACCORDANCE WITH POST-MARKET SURVEILLANCE PROCESS. A SUPPLEMENTAL REPORT WILL BE FILED IF ANY FURTHER INVESTIGATION AND/OR ADDITIONAL INFORMATION IS OBTAINED. BASED ON THE COMPLAINT REVIEW, NO HARM WAS REPORTED WITHIN THE COMPLAINT. THIS DEVICE IS MARKETED UNDER EUA (B)(4) CHECK-IT.
A COMPLAINT WAS REPORTED STATING, "MULTIPLE FALSE POSITIVE RESULTS" IN ASSOCIATION BETWEEN TWO KIT LOT NUMBERS (K08A110401224M2 AND K08A111001223M2). THE COMPLAINANT WAS CONTACTED TO PROVIDED ADDITIONAL INFORMATION. NO ADDITIONAL INFORMATION WAS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1988049 | CHECK-IT | COVID-19 TEST KIT | QJR | LUCIRA HEALTH, INC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Unknown | Congenital Anomaly| O |